Literature DB >> 26961745

Using the common sense model of illness to examine interrelationships between symptom severity and health outcomes in end-stage osteoarthritis patients.

Simon R Knowles1, Elizabeth A Nelson2, David J Castle3, Michael R Salzberg3, Peter F M Choong2, Michelle M Dowsey4.   

Abstract

OBJECTIVE: The aim was to evaluate the utility of the common sense model (CSM) in characterizing contributors to psychological well-being and quality of life (QoL) in patients with end-stage OA.
METHODS: One hundred and twenty patients [34 males, 86 females; mean (s.d.) age 65.52 (9.14) years] with end-stage OA (57.5% hip, 42.5% knee) were recruited. OA symptom severity was evaluated according to the WOMAC; coping styles were assessed with the Carver Brief COPE scale; illness perceptions were explored with the Brief Illness Perceptions Questionnaire; self-efficacy was assessed with the Arthritis Self-efficacy scale; anxiety, depression and overall distress were measured using the Hospital Anxiety and Depression Scale; and QoL was assessed using the WHO Quality of Life-short version. The CSM was used to explore the interrelationships between OA symptom severity, illness perceptions and coping strategies in patients.
RESULTS: Two structural equation models were developed, with both found to have good fit. Consistent with the CSM, the standard model indicated that self-reported OA symptom severity directly influenced illness perceptions, which in turn had direct impacts upon maladaptive coping, distress and QoL. The addition of self-efficacy to the CSM resulted in a complex interaction, with OA severity directly influencing self-efficacy and self-efficacy influencing maladaptive coping, distress and QoL.
CONCLUSION: We found interrelationships amongst OA activity, illness perceptions, coping strategies, self-efficacy, psychological distress and QoL broadly consistent with the CSM. The CSM may help inform the approach to the psychological support that patients with end-stage OA often require.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  common sense model of illness; mental health; osteoarthritis; patient-reported outcomes; quality of life; self-reported OA symptom severity

Year:  2016        PMID: 26961745     DOI: 10.1093/rheumatology/kew022

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Treatment Beliefs Underlying Intended Treatment Choices in Knee and Hip Osteoarthritis.

Authors:  Ellen M H Selten; Rinie Geenen; Henk J Schers; Frank H J van den Hoogen; Roelien G van der Meulen-Dilling; Willemijn H van der Laan; Marc W Nijhof; Cornelia H M van den Ende; Johanna E Vriezekolk
Journal:  Int J Behav Med       Date:  2018-04

2.  Exploring the Impact of Illness Perceptions, Self-efficacy, Coping Strategies, and Psychological Distress on Quality of Life in a Post-stroke Cohort.

Authors:  Catherine Minshall; Chantal F Ski; Pragalathan Apputhurai; David R Thompson; David J Castle; Zoe Jenkins; Simon R Knowles
Journal:  J Clin Psychol Med Settings       Date:  2021-03

3.  Disease Knowledge, Illness Perceptions, and Quality of Life in Adolescents With Sickle Cell Disease: Is There a Link?

Authors:  Monika Rani Asnani; Antoinette Barton-Gooden; Marlyn Grindley; Jennifer Knight-Madden
Journal:  Glob Pediatr Health       Date:  2017-11-07

4.  High self-efficacy - a predictor of reduced pain and higher levels of physical activity among patients with osteoarthritis: an observational study.

Authors:  Åsa Degerstedt; Hassan Alinaghizadeh; Carina A Thorstensson; Christina B Olsson
Journal:  BMC Musculoskelet Disord       Date:  2020-06-13       Impact factor: 2.362

5.  Understanding sciatica: illness and treatment beliefs in a lumbar radicular pain population. A qualitative interview study.

Authors:  Robert Goldsmith; Nefyn Howard Williams; Fiona Wood
Journal:  BJGP Open       Date:  2019-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.